[Tyrosine kinase receptor-mediated signal transduction and cancer treatment].
Zhu
Xiao-feng
XF
Cancer Center, Sun Yat-sen University of Medical Sciences, Guangzhou 510060, China. xfzhu70@public.guangzhou.gd.cn
Liu
Zong-chao
ZC
Zeng
Yi-xin
YX
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D006801:Humans; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D015398:Signal Transduction; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D020794:Receptor Protein-Tyrosine Kinases; D000068878:Trastuzumab